Reciprocally, upon TRPV2 silencing in the metastatic melanoma cell lines (WM266.4 and 451Lu), both serum‐induced migration and, to a greater extent, invasion (through a matrigel layer) were strongly hampered (by 40–80% and 65–95%, respectively). Here, TRPV2 is linked to melanoma.